Comparison of antibiotic discs from different sources

Area of Science:

• Microbiology
• Clinical Diagnostics
• Pharmaceutical Science

Background:

• Accurate antibiotic sensitivity testing is crucial for effective antimicrobial therapy.
• Variations in antibiotic disc content and performance across manufacturers can affect clinical outcomes.
• Standardization of antibiotic susceptibility testing (AST) components is essential for reliable results.

Purpose of the Study:

• To compare the performance of antibiotic susceptibility testing discs from different manufacturers.
• To identify potential variations in antibiotic content and zone sizes produced by various brands.
• To assess the impact of manufacturer differences on the accuracy of diffusion-sensitivity tests.

Main Methods:

• Diffusion-sensitivity tests were conducted using antibiotic discs from multiple manufacturers (Oxoid, Mast, AB Biodisk, Difco, Baltimore Biological Laboratories).
• Discs with comparable antibiotic content were tested against microbial strains with known sensitivities.
• Zone sizes of bacterial inhibition were measured and compared across different disc sources.

Main Results:

• Oxoid and Mast discs produced significantly larger inhibition zones (1-5 mm) for penicillin, ampicillin, cephalothin, methicillin, carbenicillin, erythromycin, chloramphenicol, and trimethoprim compared to other brands.
• Discs containing aminoglycosides, lincomycin, fusidic acid, tetracycline, nalidixic acid, high-potency penicillin, and polymyxin B showed consistent zone sizes across manufacturers.
• Intra-manufacturer batch variability for single discs was minimal, but Multodisks sometimes yielded larger zones than single discs from the same source.

Conclusions:

• Manufacturer choice significantly impacts the zone sizes for several commonly used antibiotics in diffusion-sensitivity tests.
• These variations may have implications for the interpretation of antibiotic susceptibility results and subsequent treatment decisions.
• Further standardization and quality control are recommended for antibiotic disc manufacturers to ensure consistent performance in clinical laboratories.